Linking retinal microvasculature features with severity of diabetic retinopathy using optical coherence tomography angiography

Investigative Ophthalmology and Visual Science

Volumn 57, Issue 9, 2016, Pages 519-525

  Bhanushali, Devanshi ^a   Anegondi, Neha ^a   Gadde, Santosh G K ^a   Srinivasan, Priya ^a   Chidambara, Lavanya ^a   Yadav, Naresh Kumar ^a   Roy, Abhijit Sinha ^a  

^a Narayana Health City   (India)

Author keywords

Angiography; Blood vessels; Fractal analysis; Optical coherence tomography; Retina

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RETINA ANGIOGRAPHY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA CAPILLARY; SENSITIVITY AND SPECIFICITY; COMPLICATION; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; MICROCIRCULATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETINA FOVEA; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; FUNDUS OCULI; HUMANS; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VESSELS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84980385916     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-18901     Document Type: Article

References (33)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047–1053.
2. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994; 112: 1217–1228.
3. Rema M, Pradeepa R. Diabetic retinopathy: an Indian perspective. Indian J Med Res. 2007; 125: 297–310.
4. Spaide RF, Klancnik JM, Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015; 133: 45–50.
5. de Carlo TE, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA).Int J Retina Vitreous. 2015; 1: 1.
6. Couturier A, Mane V, Bonnin S, et al. Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina. 2015; 35: 2384–2391.
7. Matsunaga DR, Yi JJ, De Koo LO, Ameri H, Puliafito CA, Kashani AH. Optical coherence tomography angiography of diabetic retinopathy in human subjects. Ophthalmic Surg Lasers Imaging Retina. 2015; 46: 796–805.
8. Takase N, Nozaki M, Kato A, Ozeki H, Yoshida M, Ogura Y. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015; 35: 2377–2383.
9. Spaide RF, Fujimoto JG, Waheed NK. Image artifacts in optical coherence tomography angiography.Retina. 2015; 35: 2163–2180.
10. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology. 1991; 98: 786–806.
11. Taud H, Parrot JF. Measurement of DEM roughness using the local fractal dimension.Géomorphologie. 2005; 11: 327–338.
12. Gadde SG, Anegondi N, Bhanushali D, et al. Quantification of vessel density in retinal optical coherence tomography angiography images using local fractal dimension. Invest Ophthalmol Vis Sci. 2016; 57: 246–252.
13. Freiberg FJ, Pfau M, Wons J, Wirth MA, Becker MD, Michels S. Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2015; 254: 1051–1058.
14. Hwang TS, Jia Y, Gao SS, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina. 2015; 35: 2371–2376.
15. Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol. 2015; 160: 35–44.e1.
16. Di G, Weihong Y, Xiao Z, et al. A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2015; 254: 873–879.
17. de Carlo TE, Chin AT, Bonini Filho MA, et al. Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography. Retina. 2015; 35: 2364–2370.
18. Conrath J, Giorgi R, Raccah D, Ridings B. Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment. Eye (Lond). 2005; 19: 322–326.
19. Agemy SA, Scripsema NK, Shah CM, et al. Retinal vascular perfusion density mapping using optical coherence tomography angiography in normals and diabetic retinopathy patients. Retina. 2015; 35: 2353–2363.
20. Hammes HP, Feng Y, Pfister F, Brownlee M. Diabetic retinopathy: targeting vasoregression. Diabetes. 2011; 60: 9–16.
21. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye (Lond). 2002; 16: 242–260.
22. Hwang TS, Gao SS, Liu L, et al. Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy. JAMA Ophthalmol. 2016; 134: 336–373.
23. Krishnamurti U, Steffes MW. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem. 2001; 47: 1157–1165.
24. Cho NH, Kim TH, Woo SJ, et al. Optimal HbA1c cutoff for detecting diabetic retinopathy. Acta Diabetol. 2013; 50: 837–842.
25. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995; 44: 968–983.
26. Frank RN. Diabetic retinopathy and systemic factors. Middle East Afr J Ophthalmol. 2015; 22: 151–156.
27. Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health. 2015; 73: 43.
28. Shahlaee A, Samara WA, Hsu J, et al. In vivo assessment of macular vascular density in healthy human eyes using optical coherence tomography angiography. Am J Ophthalmol. 2016; 165: 39–46.
29. Yu J, Jiang C, Wang X, et al. Macular perfusion in healthy Chinese: an optical coherence tomography angiogram study. Invest Ophthalmol Vis Sci. 2015; 56: 3212–3217.
30. Bonnin S, Mane V, Couturier A, et al. New insight into the macular deep vascular plexus imaged by optical coherence tomography angiography. Retina. 2015; 35: 2347–2352.
31. Zhang M, Hwang TS, Campbell JP, et al. Projection-resolved optical coherence tomographic angiography. Biomed Opt Express. 2016; 7: 816–828.
32. Mastropasqua R, Di Antonio L, Di Staso S, et al. Optical coherence tomography angiography in retinal vascular diseases and choroidal neovascularization. J Ophthalmol. 2015; 2015: 343515.
33. Jia Y, Morrison JC, Tokayer J, et al. Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express. 2012; 3: 3127–3137.